share

(9S)-9-Deoxo-9-[[(4-Iodophenyl)Sulfonyl]Amino]Erythromycin CAS NO 61066-19-1


Unit Price:

CAS No.:61066-19-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(9S)-9-Deoxo-9-[[(4-Iodophenyl)Sulfonyl]Amino]Erythromycin is a chemically modified erythromycin derivative, a key intermediate in the synthesis of advanced macrolide antibiotics. This compound is valued for its role in developing novel therapeutic agents with potentially enhanced activity against resistant bacterial strains. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on next-generation antibiotic development and specialized chemical synthesis.

Application

  • Pharmaceutical Intermediate: A critical building block in the synthesis of novel macrolide antibiotic candidates and active pharmaceutical ingredients (APIs).
  • Antibacterial Research: Used in medicinal chemistry programs to study structure-activity relationships (SAR) and develop new antibacterial agents.
  • Chemical Synthesis: Serves as a specialized starting material or intermediate for complex organic transformations in fine chemical production.
  • Biochemical Research: Employed in studies investigating bacterial protein synthesis inhibition and mechanisms of antibiotic action.
  • Reference Standard: Used as a high-purity analytical standard for quality control and regulatory testing in pharmaceutical manufacturing.

Basic Information

Product Name (9S)-9-Deoxo-9-[[(4-Iodophenyl)Sulfonyl]Amino]Erythromycin
CAS No. 61066-19-1
Molecular Formula C37H66IN2O12S
Molecular Weight 905.90 g/mol
Synonyms 9-Deoxo-9-[(4-iodophenyl)sulfonyl]aminoerythromycin; 9(S)-9-Deoxo-9-[(4-iodophenyl)sulfonylamino]erythromycin; Erythromycin, 9-deoxo-9-[[(4-iodophenyl)sulfonyl]amino]-; 9-Deoxo-9-(4-iodobenzenesulfonamido)erythromycin; 9-Deoxo-9-(N-(4-iodophenyl)sulfonyl)aminoerythromycin; 61066-19-1; (9S)-9-Deoxo-9-[[(4-iodophenyl)sulfonyl]amino]erythromycin
EINECS Contact for details

Quality Control

Our (9S)-9-Deoxo-9-[[(4-Iodophenyl)Sulfonyl]Amino]Erythromycin is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) with detailed specifications are provided and can be tailored to meet specific project or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (typically 15-25°C). The product should be kept under inert atmosphere if long-term stability is required. Handle and store in accordance with good laboratory practices.

Specification

Item Specification
Appearance White to off-white powder
Identification (HPLC) Conforms
Identification (IR) Conforms to reference spectrum
Assay (HPLC) ≥ 95.0%
Related Substances (HPLC) Total impurities ≤ 5.0%
Water Content (KF) ≤ 2.0%
Residual Solvents (GC) Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.